January 29, 2025 11:13 GMT
HEALTHCARE: Danaher (DHR: A3 pos/A-): 4Q24
HEALTHCARE
Slight miss on EPS, initial reaction is -4% in the overnight session
- Revenues $6.5bn +2% yoy; Full Year $23.9bn Flat yoy
- Guidance for 2025: Q1 decline low-single-digits; FY25 revenue +3%
- Q4 Adj Op Margin 29.6% +90bps; FY 28.6% -10bps
- FCF +3.5% for full year to $5.31bn
- Biotech and Life Sciences improved (end of destocking) but Diagnostics saw a -3% fall in revenue and -170bps reduction in margin
- Issuance is not expected: only one 2025 bond.
69 words